The interaction of representative members from two classes of antimycotics--the azoles and the allylamines--with cytochromes P-450 in steroidogenic tissues and liver.

Spectrophotometric studies with ketoconazole, clotrimazole and miconazole show strong type-II interactions with several cytochromes P-450, particularly (Ks greater than 10(7)M-1; pH7.4; 25 degrees C) with the 11 beta-hydroxylase of adrenal mitochondria, with the 17 alpha/20 lyase of testis microsomes and with some forms of cytochromes P-450 of liver. A tight binding of the azoles also occurs to the reduced cytochromes, giving rise to an impeded CO binding to the haem iron. The binding of the azoles to 11 beta-hydroxylase and 17 alpha/20 lyase is much tighter than the binding of endogenous substrates, and consequently inhibition of steroidogenesis will occur at these sites. The metabolism of xenobiotic substrates by the cytochromes P-450 of liver will also be severely impeded. In contrast, the allylamines naftifine and SF 86-327 are type-I substrates for a small portion of cytochromes P-450 of liver microsomes only and there is no spectral evidence for binding to the cytochromes P-450 involved in steroid biosynthesis.

[1]  J. Trachtenberg Ketoconazole therapy in advanced prostatic cancer. , 1984, The Journal of urology.

[2]  I. Edwards,et al.  Cisplatin-induced alteration of the copper and zinc content of the rat kidney. , 1985, Biochemical pharmacology.

[3]  G. Petrányi,et al.  Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphtha lenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activity. , 1984, Journal of medicinal chemistry.

[4]  J. Mason,et al.  Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[5]  N S Ryder,et al.  Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. , 1984, Science.

[6]  T. Nishikawa,et al.  Steroid concentrations in the outer and inner zones of the adrenal cortex of the guinea pig. , 1984, Journal of steroid biochemistry.

[7]  N. Ryder,et al.  Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans , 1984, Antimicrobial Agents and Chemotherapy.

[8]  H. van den Bossche,et al.  Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. , 1983, Biochemical Society transactions.

[9]  B. L. Fuller,et al.  Inhibition of thromboxane synthesis in guinea pig lung and human platelets by clotrimazole and other imidazole antifungals. , 1983, Biochemical pharmacology.

[10]  M. Rossi Structural studies of metyrapone: a potent inhibitor of cytochrome P-450. , 1983, Journal of medicinal chemistry.

[11]  J. Kowal The effect of ketoconazole on steroidogenesis in cultured mouse adrenal cortex tumor cells. , 1983, Endocrinology.

[12]  D. Wheatley,et al.  KETOCONAZOLE, CYCLOSPORIN, AND THE KIDNEY , 1982, The Lancet.

[13]  G. Daum,et al.  Squalene and ergosterol biosynthesis in fungi treated with naftifine, a new antimycotic agent , 1982 .

[14]  J. Schenkman,et al.  Hepatic cytochrome P-450 monooxygenase system , 1982 .

[15]  H. B. Levine Ketoconazole in the management of fungal disease. , 1982 .

[16]  B. Testa,et al.  Inhibitors of Cytochrome P-450s and their mechanism of action. , 1981, Drug metabolism reviews.

[17]  H. van den Bossche,et al.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis , 1980, Antimicrobial Agents and Chemotherapy.

[18]  R. Ebel,et al.  Substrate binding to hepatic microsomal cytochrome P-450. Influence of the microsomal membrane. , 1978, The Journal of biological chemistry.

[19]  H. van den Bossche,et al.  Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. , 1978, Chemico-biological interactions.

[20]  R. Rumbaugh,et al.  Differential control of adrenal drug and steroid metabolism in the guinea pig. , 1977, Life sciences.

[21]  A. Ehrenberg,et al.  Heterogeneity of cytochrome P‐450 in rat liver microsomes: Selective interaction of metyrapone and SKF 525‐A with different fractions of microsomal cytochrome P‐450 , 1975, FEBS letters.

[22]  G. Betz,et al.  Participation of cytocheome P-450 in the steroid 17α-hydroxylase of testis microsomes , 1975, Steroids.

[23]  R. Mailman,et al.  Cytochrome P-450 difference spectra: effect of chemical structure on type II spectra in mouse hepatic microsomes. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[24]  G. S. Boyd,et al.  Spectral properties of rat adrenal-mitochondrial cytochrome P-450. , 1974, European journal of biochemistry.

[25]  M. Webber International Encyclopedia of Pharmacology and Therapeutics , 1972 .

[26]  G. S. Boyd,et al.  pH‐Dependent changes in the spin state of cytochrome P450 from adrenal mitochondria , 1971, FEBS letters.

[27]  R. Estabrook,et al.  Cytochrome P-450 of liver microsomes--one pigment or many. , 1968, Biochemical and biophysical research communications.

[28]  G. S. Boyd,et al.  The cholesterol side-chain cleavage system of bovine adrenal cortex. , 1967, European journal of biochemistry.

[29]  T. Omura,et al.  [90] Isolation of cytochromes P-450 and P-420 , 1967 .

[30]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .